Autoantibodies News and Research

RSS
Severe COVID-19 characterized by phosphorylation of STAT1

Severe COVID-19 characterized by phosphorylation of STAT1

SARS-CoV-2 Spike may trigger production of antibodies that cross-react with human thrombopoietin to induce thrombocytopenia

SARS-CoV-2 Spike may trigger production of antibodies that cross-react with human thrombopoietin to induce thrombocytopenia

Certain intestinal bacteria induce cross-reactive IgA responses to the SARS-CoV-2 spike RBD

Certain intestinal bacteria induce cross-reactive IgA responses to the SARS-CoV-2 spike RBD

Clinical trials during a pandemic – lessons from COVID-19

Clinical trials during a pandemic – lessons from COVID-19

Can prior human seasonal coronavirus antibody response patterns predict SARS-CoV-2 inhibition?

Can prior human seasonal coronavirus antibody response patterns predict SARS-CoV-2 inhibition?

Functional autoantibody in COVID-19 contributes to the 'firestorm' of blood clots and inflammation

Functional autoantibody in COVID-19 contributes to the 'firestorm' of blood clots and inflammation

A drug candidate to prevent adverse reactions due to COVID-19 infection or vaccines

A drug candidate to prevent adverse reactions due to COVID-19 infection or vaccines

USF receives $69.9 Million NIH funding to continue study on type 1 diabetes

USF receives $69.9 Million NIH funding to continue study on type 1 diabetes

New AI systems offers quicker, more accurate diagnosis for blistering disease

New AI systems offers quicker, more accurate diagnosis for blistering disease

Angiotensin II type 1 receptor-targeting autoantibodies may increase COVID-19 severity

Angiotensin II type 1 receptor-targeting autoantibodies may increase COVID-19 severity

Is mild COVID-19 in children due to stronger antiviral innate immunity in the upper airway?

Is mild COVID-19 in children due to stronger antiviral innate immunity in the upper airway?

Researchers study COVID-19 immune dysfunction in relation to phosphatidylserine

Researchers study COVID-19 immune dysfunction in relation to phosphatidylserine

Immunomodulatory therapies for nephrological autoimmune diseases may help treat severe COVID-19

Immunomodulatory therapies for nephrological autoimmune diseases may help treat severe COVID-19

Measuring how patterns of gene expression change in children may help predict T1D progression

Measuring how patterns of gene expression change in children may help predict T1D progression

Mast cell activation may underlie inflammation in severe COVID-19

Mast cell activation may underlie inflammation in severe COVID-19

Gestational diabetes during pregnancy can increase risk of type-1 and type-2 diabetes

Gestational diabetes during pregnancy can increase risk of type-1 and type-2 diabetes

When COVID-19 is severe, rogue antibodies attack body tissues and organs

When COVID-19 is severe, rogue antibodies attack body tissues and organs

Are COVID-19-related complications in children explained by abnormal immune responses?

Are COVID-19-related complications in children explained by abnormal immune responses?

Antithrombotic endothelial dysfunction is prevented by Tie2 activation in severe COVID-19

Antithrombotic endothelial dysfunction is prevented by Tie2 activation in severe COVID-19

Study uncovers a novel autoantigen in patients with narcolepsy type 1

Study uncovers a novel autoantigen in patients with narcolepsy type 1

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.